Literature DB >> 33412247

Pharmacological activity and flavonoids constituents of Artemisia judaica L aerial parts.

Fatma A Moharram1, Maii M Nagy2, Rabab A El Dib3, Mona M El-Tantawy2, Ghada G El Hossary4, Doaa G El-Hosari3.   

Abstract

ETHNO-PHARMACOLOGICAL RELEVANCE: Artemisia judaica L is an aromatic medicinal plant growing widely in Saint Katherine, Sinai, Egypt, and used in traditional medicine as a herbal remedy for antibacterial, anthelmintic, antidiabetic, analgesic and anti-inflammatory activities. Additionally, other Arabic regions commonly used it in their folk medicines for the treatment of fungal infections, atherosclerosis, cancer, diabetes, arthritis, and inflammatory-related diseases. AIM OF THE STUDY: Based on the traditional medicinal uses of A. judaica, the present study was designed to validate some of the traditional uses as the analgesic, anti-inflammatory, antipyretic, hepatoprotective, antidiabetic, and antioxidant activities of 80% aqueous methanol extract (AME) of A. judaica aerial parts as well as isolation and identification of its flavonoid content.
MATERIALS AND METHODS: AME of A. judaica aerial parts was fractionated using column chromatography and the structures of the isolated compounds were established using different spectroscopic data. Analgesic activity was evaluated using acetic acid-induced writhing in mice; antipyretic activity was assessed using yeast suspension-induced hyperthermia in rats; anti-inflammatory activity was evaluated using carrageenan-induced paw edema; the hepatoprotective effect was studied by measuring liver enzymes in carbon tetrachloride(CCl4)-induced hepatotoxicity rats while antidiabetic activity was estimated in alloxan hyperglycemia.
RESULTS: Eight flavone compounds namely luteolin 4' methyl ether 7-O-β-D-4C1-glucopyranoside (1), 8-methoxyapigenin 7-O-β-D-4C1-galactopyranoside (2), isovitexin (3), 8-methoxyluteolin 7-O-β-D-4C1-glucopyranoside (4), diosmetin (5), cirsimaritin (6), luteolin (7), and apigenin (8) were identified from AME of A. judaica. The AME was found to be non-toxic to mice up to 5 g/kg b.w. Moreover, it exhibits significant analgesic antipyretic, anti-inflammatory, antidiabetic, hepatoprotective, and antioxidant activities in a dose-dependent manner.
CONCLUSION: The AME was nontoxic; it exhibits significant analgesic, antipyretic, anti-inflammatory, antidiabetic, hepatoprotective, and antioxidant activities. Moreover, the isolated flavone was identified from AME for the first time.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Analgesic; Anti-inflammatory; Antidiabetic; Antipyretic; Artemisia judaica; Flavone; Hepatoprotective

Mesh:

Substances:

Year:  2021        PMID: 33412247     DOI: 10.1016/j.jep.2021.113777

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  3 in total

1.  Bio-Evaluation of the Wound Healing Activity of Artemisia judaica L. as Part of the Plant's Use in Traditional Medicine; Phytochemical, Antioxidant, Anti-Inflammatory, and Antibiofilm Properties of the Plant's Essential Oils.

Authors:  Hamdoon A Mohammed; Kamal A Qureshi; Hussein M Ali; Mohsen S Al-Omar; Omar Khan; Salman A A Mohammed
Journal:  Antioxidants (Basel)       Date:  2022-02-08

2.  In Vitro and In Vivo Studies of Anti-Lung Cancer Activity of Artemesia judaica L. Crude Extract Combined with LC-MS/MS Metabolic Profiling, Docking Simulation and HPLC-DAD Quantification.

Authors:  Marwa S Goda; Mohamed S Nafie; Basma M Awad; Maged S Abdel-Kader; Amany K Ibrahim; Jihan M Badr; Enas E Eltamany
Journal:  Antioxidants (Basel)       Date:  2021-12-22

3.  Dihydrohomoplantagin and Homoplantaginin, Major Flavonoid Glycosides from Salvia plebeia R. Br. Inhibit oxLDL-Induced Endothelial Cell Injury and Restrict Atherosclerosis via Activating Nrf2 Anti-Oxidation Signal Pathway.

Authors:  Ning Meng; Kai Chen; Yanhong Wang; Jiarong Hou; Wenhui Chu; Shan Xie; Fengying Yang; Chunhui Sun
Journal:  Molecules       Date:  2022-03-19       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.